Cargando…
Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells
Cancer cell growth is associated with immune surveillance failure. Nowadays, restoring the desired immune response against cancer cells remains a major therapeutic strategy. Due to the recent advances in biological knowledge, efficient therapeutic tools have been developed to support the best bio-cl...
Autores principales: | Rossi, Jean-François, Céballos, Patrice, Lu, Zhao-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567551/ https://www.ncbi.nlm.nih.gov/pubmed/31200766 http://dx.doi.org/10.1186/s40880-019-0379-3 |
Ejemplares similares
-
Dynamic Immune/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and Cancer
por: Rossi, Jean-François, et al.
Publicado: (2021) -
Effector triggered immunity: Activation of innate immunity in metazoans by bacterial effectors
por: Rajamuthiah, Rajmohan, et al.
Publicado: (2014) -
Editorial: Immunity to Fungal Infections: Insights From the Innate Immune Recognition and Antifungal Effector Mechanisms
por: Moyes, David L., et al.
Publicado: (2021) -
Tailored Immune Responses: Novel Effector Helper T Cell Subsets in Protective Immunity
por: Kara, Ervin E., et al.
Publicado: (2014) -
Immune Functional Assays, From Custom to Standardized Tests for Precision Medicine
por: Albert-Vega, Chloé, et al.
Publicado: (2018)